Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
151-165 of 2990 results
Grifols to acquire Hologic’s blood screening business for $1.85bn
By MDBR Staff Writer
Spanish healthcare firm Grifols has agreed to acquire blood screening business from its partner Hologic for around $1.85bn.
Diagnostics > In Vitro Diagnostics > News
ITL BioMedical signs distribution agreement with bioMérieux Canada
ITL BioMedical, a division of ITL, announced that it has signed a five year distribution agreement, with possible ongoing renewals, for its Safety SubCulture Unit (SCU) with bioMérieux Canada.
Diagnostics > In Vitro Diagnostics > News
Nanomix advances rapid diagnostic panel to aid emergency evaluation of sepsis
Nanomix revealed the first rapid diagnostic test panel designed to quickly evaluate patients affected by sepsis, which runs on the company's simple-to-use, handheld diagnostic system, the Nanomix eLab.
Diagnostics > In Vitro Diagnostics > News
Trovagene announces reorganization to accelerate global distribution of liquid biopsy technology
Trovagene, a developer of circulating tumor DNA (ctDNA) molecular diagnostics, announced that it will increase its focus on the global distribution of kits and systems to clinical research laboratories for the liquid biopsy oncology testing market.
Diagnostics > In Vitro Diagnostics > News
Curetis acquires qPCR-based Gyronimo platform from Carpegen and Systec
By MDBR Staff Writer
Molecular diagnostic solutions provider Curetis has acquired real-time qPCR-based Gyronimo platform from Carpegen and Systec.
Diagnostics > In Vitro Diagnostics > News
Cancer Targeted Technology begins Phase I clinical trial of CTT1057 diagnostic imaging agent for prostate cancer
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on small molecules that target pivotal enzyme targets on cancer, announced that a Phase I clinical trial has commenced in men with high risk metastatic prostate cancer.
Diagnostics > In Vitro Diagnostics > News
Pacific Edge introduces Cxbladder Monitor urine-based gene expression test in US
By MDBR Staff Writer
Cancer diagnostics firm Pacific Edge has introduced Cxbladder Monitor urine-based gene expression test in the US.
Diagnostics > In Vitro Diagnostics > News
Apax Partners acquires Unilabs from Nordic Capital and Apax Partners France
By MDBR Staff Writer
Apax Partners has acquired Switzerland-based medical diagnostic provider Unilabs from Nordic Capital and Apax Partners France.
Diagnostics > In Vitro Diagnostics > News
Novogene to open new whole genome sequencing centre in Singapore
By MDBR Staff Writer
Novogene, AITbiotech and Genome Institute of Singapore (GIS) have partnered to establish a new whole genome sequencing (WGS) centre in Singapore.
Diagnostics > In Vitro Diagnostics > News
New England Biolabs launches Luna Universal qPCR & RT-qPCR kits
New England Biolabs (NEB) has launched its Luna Universal qPCR & RT-qPCR kits, which demonstrated better performance for DNA & RNA quantitation.
Diagnostics > In Vitro Diagnostics > News
Exosome Diagnostics launches first instrument for point of care liquid biopsy
Exosome Diagnostics announced that it has developed the first instrument for exosomal protein (exoProtein) capture and analysis directly from any biofluid.
Diagnostics > In Vitro Diagnostics > News
Abbott files suit to terminate $5.8bn acquisition of diagnostics firm Alere
By MDBR Staff Writer
Healthcare firm Abbott has lodged a complaint to terminate the $5.8bn deal to acquire diagnostics device and services provider Alere.
Diagnostics > In Vitro Diagnostics > News
NantHealth signs exclusive reseller agreement with Oncotest-Teva for GPS Cancer test in Israel
NantHealth has entered into an exclusive reseller agreement with Oncotest-Teva for GPS Cancer molecular test in Israel.
Diagnostics > In Vitro Diagnostics > News
Good Start Genetics signs marketing agreement with Roche Diagnostics for carrier screening in US
By MDBR Staff Writer
Good Start Genetics has announced that it has entered into a collaborative agreement with global healthcare leader Roche to sell Good Start's carrier screening service for inherited genetic disorders.
Diagnostics > In Vitro Diagnostics > News
Evogen, UCB partner to advance development of new proteomics-based blood test
By MDBR Staff Writer
Diagnostics firm Evogen has partnered with biopharmaceutical firm UCB to advance the development of its EvoScore START for improved diagnosis of epilepsy.
Diagnostics > In Vitro Diagnostics > News
151-165 of 2990 results